ID VGF_VARV Reviewed; 140 AA.
AC P0DOQ0; P33804; Q76Q77; Q76UB3; Q89066; Q89756;
DT 16-OCT-2019, integrated into UniProtKB/Swiss-Prot.
DT 16-OCT-2019, sequence version 1.
DT 04-NOV-2026, entry version 24.
DE RecName: Full=Pro-variola growth factor;
DE Short=Pro-VGF;
DE Contains:
DE RecName: Full=Variola growth factor;
DE Short=VGF;
DE AltName: Full=Secreted epidermal growth factor-like;
DE Flags: Precursor;
GN Name=OPG019; ORFNames=B3R, B4R, C11R, D2L, D4R;
OS Variola virus.
OC Viruses; Varidnaviria; Bamfordvirae; Nucleocytoviricota; Pokkesviricetes;
OC Chitovirales; Poxviridae; Chordopoxvirinae; Orthopoxvirus;
OC Orthopoxvirus variola.
OX NCBI_TaxID=10255;
OH NCBI_TaxID=9606; Homo sapiens (Human).
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=Bangladesh-1975;
RX PubMed=8264798; DOI=10.1038/366748a0;
RA Massung R.F., Esposito J.J., Liu L.I., Qi J., Utterback T.R., Knight J.C.,
RA Aubin L., Yuran T.E., Parsons J.M., Loparev V.N., Selivanov N.A.,
RA Cavallaro K.F., Kerlavage A.R., Mahy B.W.J., Venter J.C.;
RT "Potential virulence determinants in terminal regions of variola smallpox
RT virus genome.";
RL Nature 366:748-751(1993).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=Congo-1965, Garcia-1966, and Somalia-1977;
RX PubMed=8661439; DOI=10.1006/viro.1996.0378;
RA Massung R.F., Loparev V.N., Knight J.C., Totmenin A.V., Chizhikov V.E.,
RA Parsons J.M., Safronov P.F., Gutorov V.V., Shchelkunov S.N., Esposito J.J.;
RT "Terminal region sequence variations in variola virus DNA.";
RL Virology 221:291-300(1996).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Garcia-1966;
RX PubMed=10639322; DOI=10.1006/viro.1999.0086;
RA Shchelkunov S.N., Totmenin A.V., Loparev V.N., Safronov P.F., Gutorov V.V.,
RA Chizhikov V.E., Knight J.C., Parsons J.M., Massung R.F., Esposito J.J.;
RT "Alastrim smallpox variola minor virus genome DNA sequences.";
RL Virology 266:361-386(2000).
CC -!- FUNCTION: Stimulates cellular proliferation (hyperplasia)and mobility
CC around infected cells to promote rapid and efficient spread of
CC infection. This effect is beneficial for virus replication in vivo,
CC because poxviruses replicate possibly better in proliferating cells
CC than in quiescent cells. Acts by binding host EGFR, inducing its
CC dimerization, autophosphorylation and leading to activation of several
CC cellular pathways regulating cell proliferation or cell survival. The
CC activation by host EGFR of mitogen activated protein kinases (MAPK) and
CC extracellular-signal regulated kinases (ERK) are essential for the
CC positive effect of vaccinia growth factor on poxvirus virulence in
CC vivo. {ECO:0000250|UniProtKB:P01136}.
CC -!- SUBUNIT: Variola growth factor interacts with host EGFR and promotes
CC EGFR dimerization. {ECO:0000250|UniProtKB:P01136}.
CC -!- SUBCELLULAR LOCATION: [Pro-variola growth factor]: Host membrane
CC {ECO:0000250|UniProtKB:P01136}.
CC -!- SUBCELLULAR LOCATION: [Variola growth factor]: Secreted
CC {ECO:0000250|UniProtKB:P01136}.
CC -!- INDUCTION: Expressed in the early phase of the viral replicative cycle.
CC {ECO:0000250|UniProtKB:P01136}.
CC -!- SIMILARITY: Belongs to the orthopoxvirus OPG019 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L22579; AAA60749.1; -; Genomic_DNA.
DR EMBL; U18337; AAA69306.1; -; Genomic_DNA.
DR EMBL; U18338; AAA69343.1; -; Genomic_DNA.
DR EMBL; U18340; AAA69412.1; -; Genomic_DNA.
DR EMBL; Y16780; CAB54597.1; -; Genomic_DNA.
DR PIR; C72150; C72150.
DR PIR; T28439; T28439.
DR SMR; P0DOQ0; -.
DR GlyCosmos; P0DOQ0; 2 sites, No reported glycans.
DR GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR GO; GO:0033644; C:host cell membrane; ISS:UniProtKB.
DR GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:InterPro.
DR GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR Gene3D; 2.10.25.10; Laminin; 1.
DR InterPro; IPR000742; EGF.
DR InterPro; IPR011170; GF_C11R.
DR PANTHER; PTHR10740:SF14; EGF-LIKE DOMAIN-CONTAINING PROTEIN; 1.
DR PANTHER; PTHR10740; TRANSFORMING GROWTH FACTOR ALPHA; 1.
DR PIRSF; PIRSF001779; GF_C11R; 1.
DR PRINTS; PR00009; EGFTGF.
DR SUPFAM; SSF57196; EGF/Laminin; 1.
DR PROSITE; PS00022; EGF_1; 1.
DR PROSITE; PS01186; EGF_2; 1.
DR PROSITE; PS50026; EGF_3; 1.
PE 3: Inferred from homology;
KW Disulfide bond; Early protein; EGF-like domain; Glycoprotein;
KW Growth factor; Host membrane; Host-virus interaction; Membrane; Secreted;
KW Signal; Transmembrane; Transmembrane helix.
FT SIGNAL 1..18
FT /evidence="ECO:0000255"
FT CHAIN 19..140
FT /note="Pro-variola growth factor"
FT /id="PRO_0000448105"
FT CHAIN 19..96
FT /note="Variola growth factor"
FT /evidence="ECO:0000255"
FT /id="PRO_0000448106"
FT TOPO_DOM 19..100
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 101..121
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 122..140
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT DOMAIN 41..81
FT /note="EGF-like"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT SITE 96..97
FT /note="Cleavage (By host protease)"
FT /evidence="ECO:0000255"
FT CARBOHYD 34
FT /note="N-linked (GlcNAc...) asparagine; by host"
FT /evidence="ECO:0000255"
FT CARBOHYD 95
FT /note="N-linked (GlcNAc...) asparagine; by host"
FT /evidence="ECO:0000255"
FT DISULFID 45..58
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 53..69
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT DISULFID 71..80
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT VARIANT 113
FT /note="S -> G (in strain: Garcia-1966)"
SQ SEQUENCE 140 AA; 15704 MW; F9E4D05401715F05 CRC64;
MSMKYLMLLF AAMIIRSFAN SGNAIETTLS EITNTTTDIP AIRLCGPEGN GYCFHGICIH
ARDIDGMYCR CSHGYTGIRC QHVVLVDYQR SEKPNTTTSY IPSPGIVLVL LVSIIMCCLL
FVYRFTRRTN KLPLQDMVVP
//